Join Shares and AJ Bell for an evening of investment inspiration and get to meet the decision makers behind some of the UKs fastest growing listed companies.
The event on 3 October 2018 in London will include:
- Presentations from Directors of companies to be announced
- An opportunity for you to talk directly with the Directors and ask
- Meet fellow investors and share your investing experience
- Complimentary drinks and food
More about the companies presenting:
Allergy Therapeutics (AIM:AGY) is a fully integrated commercial biotechnology company specialising in allergy vaccines.A market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments.
Mercia Technologies (MERC) is a national investment group focused on the funding and scaling of innovative businesses with high growth potential from the UK regions. Initially this is through Mercias managed funds and then selectively scaling businesses through its own balance sheet capital.
PowerHouse Energy Group (PHE) has developed a proprietary process technology - DMG® - which can utilise waste plastic, end-of-life-tyres, as well as other challenging waste streams to efficiently and economically convert them into EcoSynthesis© gas from which valuable products such as chemical precursors, hydrogen, electricity and other industrial products may be derived. The PowerHouse technology is the worlds first proven, modular, hydrogen from waste (HfW) process.
Who Should Attend
The evening is a perfect opportunity for existing shareholders or potential investors to hear from those that matter, the directors running the companies and fund managers managing their fund. Who better to explain the future potential and strategy.
Evening timings
18.00
Registration and coffee
18.30
Presentations
Dr. Mark Payton, CEO - Mercia Asset Management (MERC)
Nick Wykeman, CFO - Allergy Therapeutics (AGY)
Keith Allaun, CEO - PowerHouse Energy Group (PHE)
20.35
Drinks reception and canapés
21.30
Close